Amylyx Pharmaceuticals, Inc. - Common Stock (NQ:AMLX)

27.20 -0.23 (-0.84%)

Delayed Quote Updated: 4:00 PM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amylyx Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

50 Biggest Movers From Yesterday ↗

March 29, 2022

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares gained 81.3% to close at $2.32 on Monday. Last week, AMC Entertainment Holdings purchased a major stake in...

Via Benzinga

Amylyx Shares Plummet On Skeptical FDA Adcomm Docs On ALS Drug ↗

March 28, 2022

Via Benzinga

Mid-Day Market Update: Crude Oil Dips 8%; Plantronics Shares Spike Higher ↗

March 28, 2022

U.S. stocks traded mixed midway through trading, with the Dow dropping 175 points on Monday.

Via Benzinga

35 Stocks Moving In Monday's Mid-Day Session ↗

March 28, 2022

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) jumped 57.1% to $1.96 following reports regarding potential future investments from AMC CEO, Adam Aron....

Via Benzinga

Amylyx Pharmaceuticals Stock Crashes As FDA Doubts Its ALS Treatment ↗

March 28, 2022

Amylyx Pharmaceuticals could face an uphill battle for its ALS treatment this week.

Via Investor's Business Daily

Amylyx Pharmaceuticals Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on AMX0035

March 28, 2022

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Monday ↗

March 28, 2022

On Monday, 147 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; SAIC Profit Tops Views ↗

March 28, 2022

U.S. stocks traded mixed this morning, with the Dow dropping around 100 points on Monday.

Via Benzinga

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More ↗

March 27, 2022

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

Via Benzinga

Opening Day: AN2 Therapeutics Rises In Public Debut After Upsized IPO ↗

March 26, 2022

Shares of AN2 Therapeutics rose over 15% in its trading debut on Friday following an upsized initial public offering. This was only the second initial public offering this month, as the IPO market...

Via Talk Markets

IPO Stock Amylyx Pharmaceuticals Broke Down — But Just Wait For Its Encore ↗

March 25, 2022

Here's why a former breakdown stock, Amylyx, has run up for two consecutive days.

Via Investor's Business Daily

Amylyx Pharmaceuticals Announces Launch of U.S. Expanded Access Program for AMX0035

March 18, 2022

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

7 Biotech Stocks With Key Catalysts in March ↗

March 09, 2022

These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways.

Via InvestorPlace

Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates ↗

March 02, 2022

The Food and Drug Administration approval calendar was light in February. Nevertheless, the month saw regulatory nods accorded to some breakthrough therapies. Agios...

Via Benzinga

80 Biggest Movers From Yesterday ↗

March 02, 2022

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) jumped 78.5% to close at $0.6066 on Tuesday after jumping 36% on Monday. CTI BioPharma Corp. (NASDAQ: CTIC) surged 63...

Via Benzinga

Amylyx Pharmaceuticals Announces EMA Validation of Marketing Authorisation Application (MAA) for AMX0035 for the Treatment of ALS

February 25, 2022

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

Amylyx Pharmaceuticals Expands Executive Team with Appointment of Gina M. Mazzariello as Chief Legal Officer and General Counsel

February 23, 2022

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

73 Biggest Movers From Yesterday ↗

February 23, 2022

Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE...

Via Benzinga

50 Stocks Moving In Tuesday's Mid-Day Session ↗

February 22, 2022

Gainers Indonesia Energy Corporation Limited (NYSE: INDO) jumped 75.2% to $7.87. Imperial Petroleum Inc. (NASDAQ: IMPP) rose 52.9% to $0.7500 after declining around 7% on Friday...

Via Benzinga

FDA Sets Up Adcomm To Review Amylyx's ALS Drug Next Month ↗

February 17, 2022

The FDA's Peripheral and Central Nervous System Drugs Advisory Committee will review Amylyx Pharmaceuticals Inc's (NASDAQ: AMLX) marketing application for...

Via Benzinga

The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios ↗

February 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel...

Via Benzinga

70 Biggest Movers From Friday ↗

February 22, 2022

Gainers Sky Harbour Group Corporation (NYSE: SKYH) shares jumped 48.4% to close at $10.09 on Friday. RISE Education Cayman Ltd (NASDAQ: REDU) gained 39.7% to settle at $0.95....

Via Benzinga

Amylyx Pharmaceuticals Announces FDA Advisory Committee Meeting to Review New Drug Application for AMX0035 for the Treatment of ALS Scheduled for March 30, 2022

February 16, 2022

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

Amylyx Pharmaceuticals to Present at the 11th Annual SVB Leerink Global Healthcare Conference

February 10, 2022

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

47 Biggest Movers From Yesterday ↗

February 08, 2022

Gainers Nuvectis Pharma, Inc. (NASDAQ: NVCT) shares surged 144.6% to close at $7.95 on Monday. The company, on Friday, priced its IPO at $5 per share. Anghami Inc. (NASDAQ: ANGH...

Via Benzinga

The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News ↗

January 31, 2022

The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022 ↗

February 02, 2022

Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09...

Via Benzinga

Opening Day: Credo Rises In First Trading Day Despite Tough IPO Market ↗

January 29, 2022

Shares of Credo Technology rose more than 12% in their first trading day despite a tough IPO market. This was the first big technology offering of the year after Justworks postponed its deal that had...

Via Talk Markets

48 Biggest Movers From Yesterday ↗

January 12, 2022

Gainers Splash Beverage Group, Inc. (NYSE: SBEV) shares jumped 70.6% to close at $1.80 on Tuesday after the company announced it received authorization to sell its TapouT...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 11, 2022

Gainers Jaguar Health (NASDAQ:JAGX) stock...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.